Tissue sparing and functional recovery following experimental traumatic brain injury is provided by treatment with an anti-myelin-associated glycoprotein antibody

European Journal of Neuroscience

Volumn 24, Issue 11, 2006, Pages 3063-3072

  Thompson, Hilaire J ^a,b   Marklund, Niklas ^a,c,d   Lebold, David G ^a   Morales, Diego M ^a,c   Keck, Carrie A ^a   Vinson, Mary ^e   Royo, Nicolas C ^a   Grundy, Robert ^e   McIntosh, Tracy K ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^e GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Adhesive sticky paper test; Head injury; Hemispheric tissue loss; Myelin associated glycoprotein; Osmotic minipumps; Rat

Indexed keywords

MONOCLONAL ANTIBODY; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN ASSOCIATED GLYCOPROTEIN ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; BRAIN CORTEX; BRAIN VENTRICLE; COGNITION; CONTROLLED STUDY; DRUG INFUSION; HIPPOCAMPAL FIMBRIA; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOTOR ACTIVITY; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SENSORIMOTOR FUNCTION; SENSORY EVALUATION; THALAMUS; TRAUMATIC BRAIN INJURY;

ANIMALS; ANTIBODIES, MONOCLONAL; AXONS; BRAIN; BRAIN INJURIES; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; MALE; MYELIN-ASSOCIATED GLYCOPROTEIN; NERVE REGENERATION; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; TREATMENT OUTCOME; WALLERIAN DEGENERATION;

EID: 33845676295     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2006.05197.x     Document Type: Article

References (71)

1. Adams, J.H., Graham, D.I. & Jennett, B. (2001) The structural basis of moderate disability after traumatic brain damage. J. Neurol. Neurosurg. Psychiat., 71, 521-524.
2. Bartsch, U., Kirchhoff, F. & Schachner, M. (1989) Immunohistological localization of the adhesion molecules L1, N-CAM, and MAG in the developing and adult optic nerve of mice. J. Comp. Neurol., 284, 451-462.
3. Bentzer, P., Mattiasson, G., McIntosh, T.K., Wieloch, T. & Grande, P.O. (2001) Infusion of prostacyclin following experimental brain injury in the rat reduces cortical lesion volume. J. Neurotrauma, 18, 275-285.
4. Blokland, A., de Vente, J., Prickaerts, J., Honig, W., Markerink-van Ittersum, M. & Steinbusch, H. (1999) Local inhibition of hippocampal nitric oxide synthase does not impair place learning in the Morris water escape task in rats. Eur. J. Neurosci., 11, 223-232.
5. Bramlett, H.M. & Dietrich, W.D. (2001) Neuropathological protection after traumatic brain injury in intact female rats versus males or ovariectomized females. J. Neurotrauma, 18, 891-900.
6. Bramlett, H.M., Dietrich, W.D., Green, E.J. & Busto, R. (1997) Chronic histopathological consequences of fluid-percussion brain injury in rats: effects of post-traumatic hypothermia. Acta Neuropathol. (Berl.), 93, 190-199.
7. Bramlett, H.M., Green, E.J. & Dietrich, W.D. (1999) Exacerbation of cortical and hippocampal CA1 damage due to posttraumatic hypoxia following moderate fluid-percussion brain injury in rats. J. Neurosurg., 91, 653-659.
8. Bullock, M.R., Lyeth, B.G. & Muizelaar, J.P. (1999) Current status of neuroprotection trials for traumatic brain injury: lessons from animal models and clinical studies. Neurosurgery, 45, 207-217.
9. Caroni, P. & Schwab, M.E. (1988) Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron, 1, 85-96.
10. Caroni, P., Savio, T. & Schwab, M.E. (1988) Central nervous system regeneration: oligodendrocytes and myelin as non-permissive substrates for neurite growth. Prog. Brain Res., 78, 363-370.
11. Cheney, J.A., Brown, A.L., Bareyre, F.M., Russ, A.B., Weisser, J.D., Ensinger, H.A., Leusch, A., Raghupathi, R. & Saatman, K.E. (2000) The novel compound LOE 908 MS attenuates acute neuromotor dysfunction but not cognitive impairment or cortical tissue loss following traumatic brain injury in rats. J. Neurotrauma, 17, 83-91.
12. Cirulli, F., Berry, A., Chiarotti, F. & Alleva, E. (2004) Intrahippocampal administration of BDNF in adult rats affects short-term behavioral plasticity in the Morris water maze and performance in the elevated plus-maze. Hippocampus, 14, 802-807.
13. Dixon, C.E., Lyeth, B.G., Povlishock, J.T., Findling, R., Hamm, R., Marmarou, A., Young, H.F. & Hayes, R.L. (1987) A fluid percussion model of experimental brain injury in the rat: Neurological, physiological, and histopathological characteristics. J. Neurosurg., 67, 110-119.
14. Emerick, A.J., Neafsey, E.J., Schwab, M.E. & Kartje, G.L. (2003) Functional reorganization of the motor cortex in adult rats after cortical lesion and treatment with monoclonal antibody IN-1. J. Neurosci., 23, 4826-4830.
15. Fawcett, J.W. & Asher, R.A. (1999) The glial scar and central nervous system repair. Brain Res. Bull., 49, 377-391.
16. Filbin, M.T. (2003) Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat. Rev. Neurosci., 4, 703-713.
17. Fruttiger, M., Montag, D., Schachner, M. & Martini, R. (1995) Crucial role for the myelin-associated glycoprotein in the maintenance of axon-myelin integrity. Eur. J. Neurosci., 7, 511-515.
18. Gentleman, S.M., Roberts, G.W., Gennarelli, T.A., Maxwell, W.L., Adams, J.H., Kerr, S. & Graham, D.I. (1995) Axonal injury: a universal consequence of fatal closed head injury? Acta Neuropathol., 89, 537-543.
19. Grady, M.S., Charleston, J.S., Maris, D., Witgen, B.M. & Lifshitz, J. (2003) Neuronal and glial cell number in the hippocampus after experimental traumatic brain injury: analysis by stereological evaluation. J. Neurotrauma, 20, 929-941.
20. Graham, D.I., McIntosh, T.K., Maxwell, W.L. & Nicoll, J.A. (2000) Recent advances in neurotrauma. J. Neuropathol. Exp. Neurol., 59, 641-651.
21. Hernandez, T.D. & Schallert, T. (1988) Seizures and recovery from experimental brain damage. Exp. Neurol., 102, 318-324.
22. Hicks, R., Soares, H., Smith, D. & McIntosh, T. (1996) Temporal and spatial characterization of neuronal injury following lateral fluid-percussion brain injury in the rat. Acta Neuropathol. (Berl.), 91, 236-246.
23. Hoover, R.C., Motta, M., Davis, J., Saatman, K.E., Fujimoto, S.T., Thompson, H.J., Stover, J.F., Dichter, M.A., Twyman, R., White, H.S. & McIntosh, T.K. (2004) Differential effects of the anticonvulsant topiramate on neurobehavioral and histological outcomes following traumatic brain injury in rats. J. Neurotrauma, 21, 501-512.
24. International Brain Injury Association (2005) Brain injury facts. Alexandria, VA. http://www.internationalbrain.org/content.php?pages=facts. Accessed 10.1.05.
25. Irving, E.A., Vinson, M., Rosin, C., Roberts, J.C., Chapman, D.M., Facci, L., Virley, D.J., Skaper, S.D., Burbidge, S.A., Walsh, F.S., Hunter, A.J. & Parsons, A.A. (2005) Identification of neuroprotective properties of anti-MAG antibody: a novel approach for the treatment of stroke? J. Cereb. Blood Flow Metab., 25, 98-107.
26. Kottis, V., Thibault, P., Mikol, D., Xiao, Z.C., Zhang, R., Dergham, P. & Braun, P.E. (2002) Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth. J. Neurochem., 82, 1566-1569.
27. Laurer, H.L. & McIntosh, T.K. (2001) Pharmacologic therapy in traumatic brain injury: update on experimental treatment strategies. Curr. Pharm. Design, 7, 1505-1516.
28. Lee, D.H., Strittmatter, S.M. & Sah, D.W. (2003) Targeting the Nogo receptor to treat central nervous system injuries. Nat. Rev. Drug Discov., 2, 872-878.
29. Lenzlinger, P.M., Shimizu, S., Marklund, N., Thompson, H.J., Schwab, M.E., Hoover, R.C., Bareyre, F.M., Motta, M., Luginbuhl, A., Pape, R., Clouse, A.K., Saatman, K.E., Morganti-Kossman, C. & McIntosh, T.K. (2005) Delayed inhibition of Nogo-A does not alter injury-induced axonal sprouting but enhances recovery of cognitive function following experimental traumatic brain injury in rats. Neuroscience, 134, 1047-1056.
30. Li, S. & Strittmatter, S.M. (2003) Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury. J. Neurosci., 23, 4219-4217.
31. Maas, A.I. (2002) Guidelines for head injury: their use and limitations. Neurol. Res., 24, 19-23.
32. Marcus, J., Dupree, J.L. & Popko, B. (2002) Myelin-associated glycoprotein and myelin galactolipids stabilize developing axo-glial interactions. J. Cell Biol., 156, 567-577.
33. Marklund, N., Clausen, F., McIntosh, T.K. & Hillered, L. (2001) Free radical scavenger posttreatment improves functional and morphological outcome after fluid percussion injury in the rat. J. Neurotrauma, 18, 821-832.
34. Marklund, N., Fulp, C.T., Bareyre, F.M., Royo, N.C., Schwab, M.E., Puri, R., Hoover, R.C., Soltesz, K., McMillan, A., Mir, A.K., Spangler, Z., Millard, M., Keck, C., LeBold, D. & McIntosh, T.K. (2004) The Nogo-A neutralizing antibody 7B12 improves motor and cognitive functional outcome following traumatic brain injury in rats. Soc. Neurosci. Abstr., 230.17.
35. Marklund, N., Fujimoto, S., Morales, D., Clausen, F., Fulp, C.T., LeBold, D., Hillered, L., Strittmatter, S.M. & McIntosh, T.K. (2005) Cognitive impairment in aged mice deficient in Nogo-A/B and Nogo-66 receptor following traumatic brain injury. J. Neurotrauma, 22, 1229 [Abstract].
36. Mattiasson, G.J., Philips, M.F., Tomasevic, G., Johansson, B.B., Wieloch, T. & McIntosh, T.K. (2000) The rotating pole test: evaluation of its effectiveness in assessing functional motor deficits following experimental brain injury in the rat. J. Neurosci. Meth., 95, 75-82.
37. McIntosh, T.K., Vink, R., Noble, L., Yamakami, I., Fernyak, S. & Faden, A.I. (1989) Traumatic brain injury in the rat: Characterization of a lateral fluid percussion model. Neuroscience, 28, 233-244.
38. McKerracher, L. & Winton, M.J. (2002) Nogo on the go. Neuron, 36, 345-348.
39. McKerracher, L., David, S., Jackson, D.L., Kottis, V., Dunn, R.J. & Braun, P.E. (1994) Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron, 13, 805-811.
40. Mukhopadhyay, G., Doherty, P., Walsh, F.S., Crocker, P.R. & Filbin, M.T. (1994) A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron, 13, 757-767.
41. NIH Consensus Development Panel (1999) Consensus conference. Rehabilitation of persons with traumatic brain injury. NIH Consensus Development Panel on Rehabilitation of Persons with Traumatic Brain Injury. JAMA, 282, 974-983.
42. Paivalainen, S., Suokas, M., Lahti, O. & Heape, A.M. (2003) Degraded myelin-associated glycoprotein (dMAG) formation from pure human brain myelin-associated glycoprotein (MAG) is not mediated by calpain or cathepsin L-like activities. J. Neurochem., 84, 533-545.
43. Papadopoulos, C.M., Tsai, S.Y., Alsbiei, T., O'Brien, T.E., Schwab, M.E. & Kartje, G.L. (2002) Functional recovery and neuroanatomical plasticity following middle cerebral artery occlusion and IN-1 antibody treatment in the adult rat. Ann. Neurol., 51, 433-441.
44. Paxinos, G. & Watson, C. (1994) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
45. Pierce, J.E., Smith, D.H., Trojanowski, J.Q. & McIntosh, T.K. (1998) Enduring cognitive, neurobehavioral, and histopathological changes persist for up to one year following severe experimental brain injury in rats. Neuroscience, 87, 359-369.
46. Povlishock, J.T., Buki, A., Koiziumi, H., Stone, J. & Okonkwo, D.O. (1999) Initiating mechanisms involved in the pathobiology of traumatically induced axonal injury and interventions targeted at blunting their progression. Acta Neurochir. (Suppl. Wien), 73, 15-20.
47. Prinjha, R., Moore, S.E., Vinson, M., Blake, S., Morrow, R., Christie, G., Michalovich, D., Simmons, D.L. & Walsh, F.S. (2000) Inhibitor of neurite outgrowth in humans. Nature, 403, 383-384.
48. Quarles, R.H., Everly, J.L. & Brady, R.O. (1973) Myelin-associated glycoprotein: a developmental change. Brain Res., 58, 506-509.
49. Riess, P., Bareyre, F., Saatman, K.E., Cheney, J.A., Lifshitz, J., Raghupathi, R., Grady, M.S., Neugebauer, E. & McIntosh, T.K. (2001) Effects of chronic, post-injury cyclosporin A administration on motor and sensorimotor function following severe, experimental traumatic brain injury. Rest. Neurol. Neurosci., 18, 1-8.
50. Royo, N.C., Shimizu, S., Schouten, J.W., Stover, J.F. & McIntosh, T.K. (2003) Pharmacology of traumatic brain injury. Curr. Opin. Pharmacol., 3, 27-32.
51. Saatman, K.E., Contreras, P.C., Smith, D.H., Raghupathi, R., McDermott, K.L., Fernandez, S.C., Sanderson, K.L., Voddi, M. & McIntosh, T.K. (1997) Insulin-like growth factor-1 (IGF-1) improves both neurological motor and cognitive outcome following experimental brain injury. Exp. Neurol., 147, 418-427.
52. Sandvig, A., Berry, M., Barrett, L.B., Butt, A. & Logan, A. (2004) Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration. Glia, 46, 225-251.
53. Schachner, M. & Bartsch, U. (2000) Multiple functions of the myelin-associated glycoprotein MAG (siglec-4a) in formation and maintenance of myelin. Glia, 29, 154-165.
54. Schallert, T., Upchurch, M., Lobaugh, N., Farrar, S.B., Spirduso, W.W., Gilliam, P., Vaughn, D. & Wilcox, R.E. (1982) Tactile extinction: distinguishing between sensorimotor and motor asymmetries in rats with unilateral nigrostriatal damage. Pharmacol. Biochem. Behav., 16, 455-462.
55. Schwab, M.E. (2004) Nogo and axon regeneration. Curr. Opin. Neurobiol., 14, 118-124.
56. Silver, M.A. & Stryker, M.P. (2001) TrkB-like immunoreactivity is present on geniculocortical afferents in layer IV of kitten primary visual cortex. J. Comp. Neurol., 436, 391-398.
57. Soares, H.D., Hicks, R.R., Smith, D.H. & McIntosh, T.K. (1995) Inflammatory leukocytic recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury. J. Neurosci., 15, 8223-8233.
58. Tang, S., Woodhall, R.W., Shen, Y.J., deBellard, M.E., Saffell, J.L., Doherty, P., Walsh, F.S. & Filbin, M.T. (1997) Soluble myelin-associated glycoprotein (MAG) found in vivo inhibits axonal regeneration. Mol. Cell. Neurosci., 9, 333-346.
59. Tang, S., Qiu, J., Nikulina, E. & Filbin, M.T. (2001) Soluble myelin-associated glycoprotein released from damaged white matter inhibits axonal regeneration. Mol. Cell. Neurosci., 18, 259-269.
60. Thompson, H.J., Lifshitz, J., Marklund, N., Grady, M.S., Graham, D.I., Hovda, D.A. & McIntosh, T.K. (2005) Lateral fluid percussion brain injury: a 15-year review and evaluation. J. Neurotrauma, 22, 42-75.
61. Thompson, H.J., LeBold, D.G., Marklund, N.M., Morales, D.M., Hagner, A.P. & McIntosh, T.K. (2006) Cognitive evaluation of traumatically brain injured rats using serial testing in the Morris water maze. Rest. Neurol. Neurosci., 24, 109-114.
62. Trapp, B.D., Andrews, S.B., Wong, A., O'Connell, M. & Griffin, J.W. (1989) Co-localization of the myelin-associated glycoprotein and the microfilament components, F-actin and spectrin, in Schwann cells of myelinated nerve fibres. J. Neurocytol., 18, 47-60.
63. Venkatesh, K.F., Chivatakarn, O.F., Lee, H.F., Joshi, P.S., Kantor, D.B., Newman, B.A., Mage, R.F., Rader, C.F. & Giger, R.J. (2005) The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein. J. Neurosci., 25, 808-822.
64. Vinson, M., Strijbos, P.J., Rowles, A., Facci, L., Moore, S.E., Simmons, D.L. & Walsh, F.S. (2001) Myelin-associated glycoprotein interacts with ganglioside GT1b. A mechanism for neurite outgrowth inhibition. J. Biol. Chem., 276, 20 280-20 285.
65. Vinson, M., Rausch, O., Maycox, P.R., Prinjha, R.K., Chapman, D., Morrow, R., Harper, A.J., Dingwall, C., Walsh, F.S., Burbidge, S.A. & Riddell, D.R. (2003) Lipid rafts mediate the interaction between myelin-associated glycoprotein (MAG) on myelin and MAG-receptors on neurons. Mol. Cell. Neurosci., 22, 344-352.
66. Vyas, A.A., Patel, H.V., Fromholt, S.E., Heffer-Lauc, M., Vyas, K.A., Dang, J., Schachner, M. & Schnaar, R.L. (2002) Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration. [See comment.] Proc. Natl Acad. Sci. U.S.A., 99, 8412-8417.
67. Wang, K.C., Kim, J.A., Sivasankaran, R., Segal, R. & He, Z. (2002a) P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature, 420, 74-78.
68. Wang, K.C., Koprivica, V., Kim, J.A., Sivasankaran, R., Guo, Y., Neve, R.L. & He, Z. (2002b) Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature, 417, 941-944.
69. Weiss, M.D., Hammer, J. & Quarles, R.H. (2000) Oligodendrocytes in aging mice lacking myelin-associated glycoprotein are dystrophic but not apoptotic. J. Neurosci. Res., 62, 772-780.
70. Wong, E.V., David, S., Jacob, M.H. & Jay, D.G. (2003) Inactivation of myelin-associated glycoprotein enhances optic nerve regeneration. J. Neurosci., 23, 3112-3117.
71. Zhang, C., Raghupathi, R., Saatman, K.E., Smith, D.H., Stutzmann, J.-M., Wahl, F. & McIntosh, T.K. (1998) Riluzole attenuates cortical lesion size, but not hippocampal neuronal loss, following traumatic brain injury in the rat. J. Neurosci. Res., 52, 342-349.